Bilcare (NSE:BI) Short-Term Debt: ₹1,589 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BI Bilcare Ltd NSE:BI
37 GF Score
Price ₹96.24
GF Value ₹61.81
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bilcare Short-Term Debt?

Bilcare NSE:BI +5.00% 37 Short-Term Debt is ₹1,589 Mil as of Mar. 2026. GuruFocus rates NSE:BI with a GF Score™ of 37/100 and a GF Value™ of ₹61.81 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Bilcare's Short-Term Debt for the quarter that ended in Mar. 2026 was ₹1,589 Mil.

Bilcare's quarterly Short-Term Debt declined from Sep. 2025 (₹2,065 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,589 Mil).

Bilcare's annual Short-Term Debt increased from Mar. 2024 (₹2,103 Mil) to Mar. 2025 (₹2,173 Mil) but then declined from Mar. 2025 (₹2,173 Mil) to Mar. 2026 (₹1,589 Mil).

Bilcare Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Bilcare Short-Term Debt Related Terms

Bilcare Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Bilcare's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bilcare Short-Term Debt Chart

Bilcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,530.68 1,226.16 2,103.39 2,173.08 1,589.40

Bilcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,173.08 0.00 2,065.00 0.00 1,589.40
NSE:BI
37GF Score
Bilcare Ltd NSE:BI
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹1,589 Mil mean?
Bilcare (NSE:BI) has a Short-Term Debt of ₹1,589 Mil as of Mar. 2026.
Is Bilcare's Short-Term Debt too high?
Bilcare's current Short-Term Debt is ₹1,589 Mil. Overall, Bilcare has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bilcare's Short-Term Debt compare to ?
Bilcare's Short-Term Debt of ₹1,589 Mil can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Packaging & Containers company?
A good Short-Term Debt depends on the Packaging & Containers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Bilcare's current Short-Term Debt is ₹1,589 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bilcare stock overvalued right now?
Based on GuruFocus' analysis, Bilcare (NSE:BI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹61.81, compared to a current price of ₹96.24 — trading 55.7% above its estimated fair value. The current Short-Term Debt is ₹1,589 Mil. Bilcare's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Bilcare (NSE:BI), the current Short-Term Debt is ₹1,589 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bilcare (NSE:BI) Overvalued in 2026?

Based on GuruFocus' analysis, Bilcare stock appears to be overvalued. The current stock price of ₹96.24 is trading 55.7% above its estimated GF Value™ of ₹61.81. GuruFocus considers Bilcare to be Significantly Overvalued.

Key valuation signals for NSE:BI:

  • Short-Term Debt: ₹1,589 Mil
  • GF Value™: ₹61.81 vs. price of ₹96.24 (55.7% above fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the NSE:BI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bilcare Business Description

Comparable Companies
Other Exchanges 526853:India
Address 301 Kamal Kunj, 8 Shivaji Housing Society, Pune, MH, IND, 411016
Bilcare Ltd is an Indian company engaged in pharma packaging research solutions. It offers effective and affordable packaging solutions. It offers pharmaceutical packaging solutions comprising specialty polymer films and Aluminium foils used for packaging of solid dosage pharmaceutical products. It also provides Clinical Trial Materials (CTM) services to the pharmaceutical and biotechnology industries under Bilcare Global Clinical Supplies. It also offers packaging films solutions to ID Card industry, Specialty Films Applications, and Food packaging industry.
37GF Score

Get the complete analysis for NSE:BI

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹96.24
Price
₹61.81
GF Value